76 results
8-K
EX-99.2
CHRS
Coherus Biosciences Inc
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
totaling $6.8 million using proceeds from the Disposition. Under the preliminary assessment, the early partial prepayment of the 2027 Term Loans has … under our preliminary accounting assessment, the prepayment premium and makewhole amount totaling $6.8 million have been recorded as a reduction
8-K
EX-2.1
adrzildi7ude8
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
rhpf yaqcl
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B3
grud 21af
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
5v96nyoo1t wolh
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
4gc51vt
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
6x4om
16 Jun 23
Business combination disclosure
5:12pm
425
719jd 33eddc
16 Jun 23
Business combination disclosure
8:08am
425
ahk1x5xxole swsimdt
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
c3ifc4ln
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-99.1
4xxgjrepw ws4
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am